{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:04:01Z","timestamp":1767337441197},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.jns.2013.01.011","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T17:24:28Z","timestamp":1359998668000},"page":"53-58","source":"Crossref","is-referenced-by-count":16,"title":["Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders"],"prefix":"10.1016","volume":"326","author":[{"given":"Michael R.","family":"Pranzatelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth D.","family":"Tate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan R.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry A.","family":"Colliver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2013.01.011_bb0185","series-title":"Clinics in Developmental Medicine No. 184\u2013185, Inflammatory and autoimmune disorders of the nervous system in children","first-page":"152","article-title":"Opsoclonus-myoclonus syndrome","author":"Pranzatelli","year":"2010"},{"key":"10.1016\/j.jns.2013.01.011_bb0010","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0883073811428816","article-title":"Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome","volume":"27","author":"Tate","year":"2012","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jns.2013.01.011_bb0015","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2013.01.011_bb0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2011.12.014","article-title":"Key role of CXCL13\/CXCR5 axis for cerebrospinal fluid B cell recruitment in pediatric OMS","volume":"243","author":"Pranzatelli","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2013.01.011_bb0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2008.06.001","article-title":"Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome","volume":"44","author":"Pranzatelli","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.jns.2013.01.011_bb0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2011.02.012","article-title":"Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus","volume":"45","author":"Pranzatelli","year":"2011","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jns.2013.01.011_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cyto.b.20021","article-title":"Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers","volume":"61","author":"Khan","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jns.2013.01.011_bb0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","article-title":"The kaleidoscope of glucorticoid effects on immune system","volume":"10","author":"Zen","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jns.2013.01.011_bb0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.humimm.2005.01.022","article-title":"High-dose intravenous immunoglobulins: an option in the treatment of systemic lupus erythematosus","volume":"66","author":"Toubi","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jns.2013.01.011_bb0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-5728(93)90070-F","article-title":"Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood\u2013brain barrier damage","volume":"43","author":"Sharief","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2013.01.011_bb0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/135245859800400317","article-title":"Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis","volume":"4","author":"Rieckmann","year":"1998","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2013.01.011_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2005.03.032","article-title":"Soluble adhesion molecules in Gilles de la Tourette's syndrome","volume":"234","author":"Martino","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2013.01.011_bb0065","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/089771501300227297","article-title":"S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury","volume":"18","author":"Pleines","year":"2001","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.jns.2013.01.011_bb0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/1817-1745.57326","article-title":"Adhesion molecule levels in serum and cerebrospinal fluid in children with bacterial meningitis and sepsis","volume":"4","author":"Jaber","year":"2009","journal-title":"J Pediatr Neurosci"},{"issue":"Suppl. 11","key":"10.1016\/j.jns.2013.01.011_bb0075","first-page":"S112","article-title":"Interferon-inducible protein 10 (CXCL10) is increased in the cerebrospinal fluid of children with opsoclonus-myoclonus syndrome","volume":"62","author":"Pranzatelli","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2013.01.011_bb0080","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/CDLI.12.1.52-55.2005","article-title":"Spinal fluid abnormalities in patients with chronic fatigue syndrome","volume":"12","author":"Natelson","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jns.2013.01.011_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/MI.2005.121","article-title":"On the role of sIL-2R measurements in rheumatoid arthritis and cancers","volume":"2005","author":"Witkowska","year":"2005","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jns.2013.01.011_bb0090","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.182.3.1541","article-title":"Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses","volume":"182","author":"Maier","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2013.01.011_bb0095","first-page":"29","article-title":"High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels","volume":"10","author":"G\u00f6ttfried","year":"2000","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jns.2013.01.011_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13547500701674063","article-title":"Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review","volume":"13","author":"Bein","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.jns.2013.01.011_bb0105","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00415-010-5623-3","article-title":"Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis","volume":"257","author":"Petereit","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2013.01.011_bb0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1196\/annals.1391.022","article-title":"Interleukin-1 system in CNS stress: seizures, fever, and neurotrauma","volume":"1113","author":"Bartfai","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2013.01.011_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000243081","article-title":"Levels of IL-1beta and IL-1ra in cerebrospinal fluid of human patients after single and prolonged seizures","volume":"17","author":"Lehtim\u00e4ki","year":"2010","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jns.2013.01.011_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","article-title":"The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain\u2013Barr\u00e9 syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Sainaghi","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.jns.2013.01.011_bb0125","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pneurobio.2010.12.003","article-title":"The chemokine receptor CCR5 in the central nervous system","volume":"93","author":"Sorce","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jns.2013.01.011_bb0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1196\/annals.1423.044","article-title":"Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL","volume":"1110","author":"Le Pottier","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2013.01.011_bb0135","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/jcbfm.2009.240","article-title":"Role of chemokines in CNS health and pathology: a focus on the CCL2\/CCR2 and CXCL8\/CXCR2 networks","volume":"30","author":"Semple","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jns.2013.01.011_bb0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-5728(01)00261-2","article-title":"Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies","volume":"115","author":"Franciotta","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2013.01.011_bb0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1442-200X.2010.03215.x","article-title":"Enhanced expression of cytokines\/chemokines in cerebrospinal fluids in mumps meningitis in children","volume":"53","author":"Asano","year":"2011","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jns.2013.01.011_bb0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"Neurath","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jns.2013.01.011_bb0160","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"Uzawa","year":"2010","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2013.01.011_bb0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jneuroim.2006.03.004","article-title":"IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles","volume":"175","author":"Malmestr\u00f6m","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2013.01.011_bb0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2003-41281","article-title":"Interleukin-6 and oligoclonal IgG synthesis in children with acute disseminated encephalomyelitis","volume":"34","author":"Dale","year":"2003","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jns.2013.01.011_bb0175","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jbspin.2010.07.007","article-title":"Interleukin-6: from identification of the cytokine to development of targeted treatments","volume":"77","author":"Assier","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jns.2013.01.011_bb0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneurol.2011.148","article-title":"Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood\u2013brain barrier breakdown in neuromyelitis optica","volume":"68","author":"Uzawa","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2013.01.011_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-381300-8.00005-8","article-title":"The many face-lifts of CD4 T helper cells","volume":"107","author":"Mucida","year":"2010","journal-title":"Adv Immunol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X13000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T19:39:50Z","timestamp":1595360390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X13000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0022510X13000130"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2013.01.011","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}